Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)-Reference-Cited by-同舟云学术

Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)

Published:2021-08-31 Issue:12 Volume:26 Page:2216-2223
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yamaguchi Masafumi,Tada Hirohito^ORCID,Mitsudomi Tetsuya,Seto Takashi,Yokoi Kohei,Katakami Nobuyuki,Nakagawa Kazuhiko,Oda Makoto,Ohta Mitsunori,Sawa Toshiyuki,Yamashita Motohiro,Iked Norihiko,Saka Hideo,Higashiyama Masahiko,Nomori Hiroaki,Semba Hiroshi,Negoro Shunichi,Chiba Yasutaka,Shimokawa Mototsugu,Fukuoka Masahiro,Nakanishi Yoichi,

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-02012-9.pdf

Reference18 articles.

1. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311(7010):899–909

2. Ohta M, Tsuchiya R, Shimoyama M et al (1993) Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. J Thorac Cardiovasc Surg 106(4):703–708

3. Tada H, Tsuchiya R, Ichinose Y et al (2004) A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43(2):167–173. https://doi.org/10.1016/j.lungcan.2003.08.028

4. Wada H, Hitomi S, Teramatsu T (1996) Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 14(4):1048–1054. https://doi.org/10.1200/JCO.1996.14.4.1048

5. Kato H, Ichinose Y, Ohta M, Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy et al (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350(17):1713–1721. https://doi.org/10.1056/NEJMoa032792

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan;Japanese Journal of Clinical Oncology;2023-08-25

2. Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma;Translational Cancer Research;2023-08

3. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma;Journal of Immunology Research;2022-05-04

4. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy;JTO Clinical and Research Reports;2022-05

5. Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures;International Journal of Molecular Sciences;2022-02-18